Literature DB >> 6643696

Effect of food on bioavailability of rifampicin.

K Polasa, K Krishnaswamy.   

Abstract

The area under the plasma concentration-time curve of rifampicin was determined with and without food administration in six healthy male volunteers. Rifampicin (10 mg/kg) was administered orally in the fasting state on one occasion and following a wheat-based breakfast on another. Administration of rifampicin with food reduced mean peak plasma concentration and prolonged the time to reach peak concentration (2 versus 4 hours). Total area under the concentration-time curve from 0 to 8 hours and the rate of absorption were also significantly reduced when rifampicin was administered with food.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6643696     DOI: 10.1002/j.1552-4604.1983.tb01787.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  11 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  The effects of food on drug bioavailability.

Authors:  P A Winstanley; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

Review 3.  Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.

Authors:  Roger K Verbeeck; Gunar Günther; Dan Kibuule; Christian Hunter; Tim W Rennie
Journal:  Eur J Clin Pharmacol       Date:  2016-06-15       Impact factor: 2.953

Review 4.  [Antibiotic stewardship and Staphylococcus aureus Bacteremia].

Authors:  S Weis; A Kimmig; S Hagel; M W Pletz
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-04-04       Impact factor: 0.840

5.  Effect of food on cibenzoline bioavailability.

Authors:  J W Massarella; H P Blumenthal; T Silvestri; A Lin
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Serum Rifampicin Levels in Patients with Tuberculosis : Effect of P-Glycoprotein and CYP3A4 Blockers on its Absorption.

Authors:  Jai Prakash; Thirumurthy Velpandian; Jitender N Pande; Suresh K Gupta
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 7.  Clinical pharmacokinetics of the antituberculosis drugs.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

8.  Effects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants.

Authors:  Damayanthi Devineni; Nicole Vaccaro; Joe Murphy; Christopher Curtin; Rao N V S Mamidi; Sveta Weiner; Shean-Sheng Wang; Jay Ariyawansa; Hans Stieltjes; Ewa Wajs; Nicholas A Di Prospero; Paul Rothenberg
Journal:  Int J Clin Pharmacol Ther       Date:  2015-02       Impact factor: 1.366

9.  Influence of Rifampin-Mediated Organic Anion-Transporting Polypeptide 1B1/1B3 Inhibition on the Pharmacokinetics of Clazosentan.

Authors:  Pierre-Eric Juif; Christine Voors-Pette; Mike Ufer; Peter Dogterom; Jasper Dingemanse
Journal:  Clin Transl Sci       Date:  2019-05-06       Impact factor: 4.689

10.  Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs.

Authors:  Agibothu Kupparam Hemanth Kumar; Vedachalam Chandrasekaran; Angadi Kiran Kumar; M Kawaskar; J Lavanya; Soumya Swaminathan; Geetha Ramachandran
Journal:  Indian J Med Res       Date:  2017-04       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.